title: Treatment of psoriasis vulgaris with oral 1 alpha,25-dihydroxyvitamin D3--report of two cases.
authors.forename: S
authors.initials: S
authors.lastname: Morimoto
authors.forename: K
authors.initials: K
authors.lastname: Yoshikawa
authors.forename: T
authors.initials: T
authors.lastname: Kozuka
authors.forename: Y
authors.initials: Y
authors.lastname: Kitano
authors.forename: S
authors.initials: S
authors.lastname: Imanaka
authors.forename: K
authors.initials: K
authors.lastname: Fukuo
authors.forename: E
authors.initials: E
authors.lastname: Koh
authors.forename: T
authors.initials: T
authors.lastname: Hironaka
authors.forename: A
authors.initials: A
authors.lastname: Zen
authors.forename: T
authors.initials: T
authors.lastname: Nabata
mesh_terms: D000284:Administration, Oral; D000293:Adolescent; D002112:Calcifediol / Q000097:blood; D002116:Calcitonin / Q000097:blood; D002117:Calcitriol / Q000627:therapeutic use*; D002118:Calcium / Q000097:blood; D006801:Humans; D008297:Male; D008875:Middle Aged; D010281:Parathyroid Hormone / Q000097:blood; D010710:Phosphates / Q000097:blood; D011565:Psoriasis / Q000097:blood / Q000188:drug therapy* / Q000473:pathology; D012867:Skin / Q000473:pathology
chemical_list: D010281:Parathyroid Hormone; D010710:Phosphates; D002116:Calcitonin; D002117:Calcitriol; D002112:Calcifediol; D002118:Calcium